...
首页> 外文期刊>Journal of surgery and medicine. >An epidemiological and clinical analysis of cutaneous drug eruption: A cohort of 164 patients
【24h】

An epidemiological and clinical analysis of cutaneous drug eruption: A cohort of 164 patients

机译:皮肤爆发的流行病学与临床分析:164例患者的队列

获取原文
           

摘要

Aim: Drug reactions are important and frequent complications of medical treatments. In this study we aimed to investigate the patients hospitalized with a diagnosis of cutaneous drug eruptions, implicated drugs, and related skin manifestations considering the literature. Methods: This retrospective cohort study was performed in Haydarpa?a Numune Training and Research Hospital, Dermatology and Venereology Department. The study comprised 164 patients that were diagnosed with cutaneous drug eruption between January 2010 and December 2016. Some parameters, such as demographic characteristics, type of the reaction, culprit drug groups, multiple drug usage, time between the onset of the drug intake and beginning of the eruption were recorded. Age, gender, symptoms, laboratory tests, diagnosis and treatment information were obtained through patient files. Causal relationship was assessed by Naranjo algorithm. Adverse drug reactions were categorized as definite, probable, possible, and absent. All values were expressed in percentages. The severity of the reaction caused by the drug was assessed with Hartwig's Severity Assessment Scale. Results: Among 164 patients, there were 104 females and 60 males with a mean age of 46.3 (18.8) years. The most commonly encountered type of drug reactions were urticaria and angioedema (42.1%), followed by morbilliform drug eruption (31.7%). More cutaneous reactions were noted with NSAIDs (18.9%), antibiotics (15.2%) and the combination of NSAIDs and antimicrobial agents (9.8%). Time between the onset of eruption and the intake of the drug varied by hours to months. Some of these patients also described similar reactions related to drugs in the past. Conclusion: Knowledge of these drug eruptions, the causative drugs and the prognostic factors is important for clinicians. It is recommended to advise patients to carry a list in their wallets indicating their drug allergies and/or intolerances, especially if they had a severe reaction before. We conclude that a careful follow-up should be performed with NSAIDs, antibiotics and anti-epileptics. The combination of drugs, including NSAIDs and antibiotics should be avoided as much as possible.
机译:目的:药物反应是医学治疗的重要和频繁的并发症。在这项研究中,我们旨在调查住院患者的患者,诊断皮肤灭火,牵连药物和相关的皮肤表现形式考虑到文献。方法:该回顾性队列研究在Haydarpa进行了吗?Numune培训和研究医院,皮肤病学和住症部门。该研究包括164名患者,该患者被诊断为2010年1月至2016年12月的皮肤爆发。一些参数,如人口统计学特性,反应类型,罪魁祸首药物,多种药物使用,药物摄入的发作之间的时间和开始爆发的爆发。通过患者文件获得年龄,性别,症状,实验室测试,诊断和治疗信息。 Naranjo算法评估了因果关系。不良药物反应分类为明确,可能的,可能的,不存在。所有值均以百分比表示。用Hartwig严重评估规模评估药物引起的反应的严重程度。结果:164名患者中,有104名女性和60名男性,平均年龄为46.3(18.8)年。最常见的药物反应类型是荨麻疹和血管皮,其次是Morbilliform药物喷发(31.7%)。 NSAIDS(18.9%),抗生素(15.2%)和NSAIDs和抗微生物剂(9.8%)的组合进行了更多的皮肤反应。喷发开始和药物的摄入之间的时间变化了数小时至数月。其中一些患者还描述了过去与药物有关的类似反应。结论:了解这些药物爆发,致病药物和预后因素对临床医生很重要。建议建议患者在他们的钱包中携带列表,表明他们的药物过敏和/或不容忍,特别是如果它们之前具有严重反应。我们得出结论,应使用NSAID,抗生素和抗癫痫作用进行仔细的随访。应尽可能避免药物组合,包括NSAIDs和抗生素。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号